Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-154287)
Michael Smith Foundation for Health Research
Received: 22 September 2020
Accepted: 6 January 2021
First Online: 9 April 2021
: E.F.H. and R.E.W.H. have filed patents related to the antibiofilm and immunomodulatory functions of synthetic HDPs. These patents have been assigned to their employer, the University of British Columbia, and licensed to ABT Innovations Inc., in which R.E.W.H. has an ownership position.